Monster Beverage Corp (MNST): what the price requires

At today's price, Monster Beverage Corp (MNST) is priced for +28.5% growth. boothcheck doesn't publish a fair value or a price target; it shows what the price assumes, so you can judge whether that bar is too high.

Generated: 2026-07-13 · Source: https://boothcheck.com/report/MNST

Headline

FieldValue
TickerMNST
CompanyMonster Beverage Corp
Current price$97.20/sh
CompositionMonster Energy Drinks 93% / Strategic Brands 6% / Alcohol Brands 2%

What The Price Requires (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Operating margin needed9.5%
Operating margin today30.6%
Margin compression implied-21.1pp
Implied growth28.5%
Multiple paid36x operating income

The operating-margin requirement is derived from the framework's value band at year 12, a separately labeled basis from the headline growth/duration solve.

Solve inputs: computed at a 8.6% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~8.2pp.

How unusual the bet is: high

ReferenceValue
vs own history+1.26σ
cohort percentile (of 69 peers)86
sustained it ~5 years at this level30%
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset3.69x4expensive
Earnings4.18x3expensive
Relative5.46x3expensive
Growth0.88x3justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings, Relative

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 9.3%); the inversion above states its own rate.

Per-Model Detail (n=13)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$75.731.28xyesFCF base $2.4B, growth 18% (input: historical growth), terminal g 4.0%, WACC 9.3%, 6yr projection
DCF Exit MultipleGrowth$117.530.83xyesExit EV/EBITDA: 34.0x / 36.0x / 38.0x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelative$17.805.46xyesP/S fallback (negative EPS): Sector P/S 2.0x × TTM revenue — excluded from consensus
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$22.234.37xyesBV/sh $8.83, ROE (TTM) 23.3%, ke 9.3%
Two-Stage Excess ReturnAsset$35.212.76xyes5yr excess ROE then converge to ke=9.3%
Discounted Future Market CapGrowth$110.080.88xyesRev $8.8B, growth 18% (input: historical growth; tapered), Terminal P/S: 8.9x / 10.9x / 12.9x (bear / base = today's held flat / bull, cap 12x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$19.944.87xyesNormalized EBIT (5y avg op income, one-time charges added back) $2.02B × (1−24%) / WACC 9.3% → EPV (no growth)
Residual IncomeAsset$32.393.00xyesBV $8.83 + 5yr PV of (ROE (TTM) 23.3% − Kₑ 9.3%) × BV; BV grows 8.8%/yr
Graham NumberAssetno
EV/EBITDA RelativeRelative$39.012.49xyesEBITDA $2.61B × sector EV/EBITDA 14.0x
FCF YieldEarnings$24.733.93xyesFCF $2071.7M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$23.274.18xyesSBC-adj FCF $1.94B (FCF $2.07B − SBC $0.13B) capitalized at Kₑ
Ben Graham FormulaEarningsno
ROIC-Justified P/BAsset$7.9112.29xyesBV $8.83 × (ROIC 8.3% / WACC 9.3%)
P/Sales SectorRelative$17.805.46xyesRevenue $8.79B × sector P/S 2.0x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Solvency

FieldValue
Net cash$2.8b
Net debt / NOPAT (after-tax)-1.40x (net cash)
Net debt / operating income (pre-tax)-1.07x (net cash)
Share count CAGR (buyback)-2.0%
Burning cashno

Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.

Bullet Takeaways

Bull Case

The earnings trajectory is the clearest argument, because everything about it is pointing up and accelerating. First-quarter net sales rose 26.9% to $2.35 billion, operating income grew 28.1% to $730 million, and earnings per share climbed 27.6% to $0.58, beating estimates. The growth was led by the core Monster Energy segment, up 27.6%, but the standout was international: sales outside the United States jumped 44.9% to $1.06 billion, now about 45% of the total. When the biggest part of the business grows in the high twenties and the international half grows in the forties, the company is compounding from two engines at once.

The economics behind that growth are exceptional. Monster runs a near-30% operating margin, earns a return on equity above 23%, and converts revenue to cash so efficiently that it holds a net cash position of nearly $2.8 billion with almost no debt. An energy drink is a simple product with an addictive consumption pattern and a strong brand, which is the recipe for high margins and recurring purchases. The company funds its growth entirely from internal cash and still has the firepower to buy back stock, with the board just authorizing an additional $500 million repurchase.

The distribution moat is the durable advantage. Monster's products reach approximately "158 countries and territories worldwide," and the brands move through the Coca-Cola bottling and distribution system, one of the most extensive beverage networks on earth. That partnership is hard for a challenger to replicate: signing up the global Coca-Cola system took Monster years and a strategic relationship, and it gives the company shelf placement and cold-box access in markets where a newer rival has to build distribution from scratch. The bull case is that Monster is a high-margin, net-cash, globally distributed brand still growing in the high twenties with a long international runway, and that the premium multiple reflects a genuine compounder the static valuation lenses cannot frame.

Bear Case

The bear case begins with what the price requires, because the assumption is steep. At $91.35 (as of June 27, 2026) the market is paying about thirty-four times operating income, a multiple at the very top of the beverage peer distribution, and that price embeds roughly 27% annual operating growth sustained for five years. Monster is delivering that pace right now, so the rate is not the leap; the duration is. Only about 32% of comparable fast-growers have held such growth even five years, and the energy-drink category is more contested today than at any point in Monster's history. The price is paying for the rare outcome in a market that is getting harder, not easier.

The competition is named and well-funded. Monster's own 10-K lists the field: it competes with "Red Bull GmbH, KDP, Molson Coors, Constellation Brands, AB InBev, The Boston Beer Company and The Mark Anthony Group," and crucially with newer entrants "such as CELSIUS, PRIME, C4, Alani Nu, GHO"ST. These are not fringe players: Celsius and Prime have taken meaningful shelf space and consumer attention, particularly among younger and health-oriented drinkers, the exact demographic energy drinks chase. The company also faces "competition from new entrants in the energy drink, energy shot, beer and beyond beer categories." A premium multiple assumes Monster keeps winning; the competitive set assumes it has to fight harder for every point of share.

The margin is already showing the strain. First-quarter gross margin fell to 55.0% from 56.5%, pressured by geographic mix, higher aluminum can costs, and elevated freight. As Monster grows internationally, the mix shifts toward lower-margin geographies, and input costs are outside its control. A company priced for 27% growth at peak margins has two ways to disappoint: the growth decelerates as competition bites, or the margin compresses as costs and mix erode it, and a high price magnifies either outcome. The balance sheet is a fortress, net cash and no debt, so this is not a solvency story. It is a valuation-and-competition story: a wonderful business priced as if its best, most contested years are guaranteed to repeat for the rest of the decade.

Valuation

The bet in the price is demanding but, unusually, matched by the current run-rate. At $91.35 the market pays about thirty-four times trailing operating income, which inverts to roughly 27% annual operating growth held for five years. Monster grew operating income 28% last quarter, so the implied rate is close to what it is delivering. The stretch is the duration and the fact that the multiple sits at the very top of the beverage peer distribution, well beyond the upper quartile, with only about 32% of comparable fast-growers having sustained such a pace for five years.

The methods make the shape of the bet explicit: only the growth-based cash-flow lens reaches the price, while asset value, earnings power, and peer multiples all read the stock as richly valued. This is the durability-premium pattern. The static frames capitalize today's profit and cannot price the franchise value of a globally distributed, high-margin brand still compounding in the high twenties, so they land far below the price. The premium is the optionality on continued growth, isolated where an investor can weigh it. The peer-multiple lens is the most stretched, placing fair value far under the price, which is the market's way of saying Monster trades at a premium to every other beverage company precisely because investors believe its growth and margin profile justify it.

Solvency is a strength that takes the downside-survival question off the table. Monster holds nearly $2.8 billion of net cash, carries almost no debt, and generates more than $2 billion of free cash flow a year, enough to fund growth and buy back stock at the same time. The share count is falling about 2% a year through repurchases, which compounds per-share value on top of the operating growth. The decisive question for the valuation is therefore not the balance sheet, which is pristine, but durability against competition: whether Monster can hold its growth rate and its near-30% margin against Celsius, Prime, and the rest of a crowded field long enough to justify a top-of-peer multiple. At this price, the business has to keep executing at its best, and the cost of a slowdown is steep.

Catalysts

Monster Beverage's first-quarter 2026 results were strong across the board and the stock responded. Net sales rose 26.9% to $2.35 billion, beating estimates by roughly 9%, operating income grew 28.1% to $730 million, and EPS climbed 27.6% to $0.58, ahead of the $0.53 forecast. The core Monster Energy segment grew 27.6%, and international sales surged 44.9% to $1.06 billion, now about 45% of the total. The board approved an additional $500 million share-repurchase program alongside the results.

The forward picture balances momentum against two pressures. The growth catalysts are continued international expansion through the Coca-Cola distribution system, new product launches across the energy and beyond-beer categories, and the early alcohol-brand initiatives. The watch items on the other side are margin and competition: first-quarter gross margin slipped to 55.0% from 56.5% on higher aluminum can and freight costs and geographic mix, and the energy-drink category faces intensifying pressure from well-funded entrants like Celsius and Prime. The most important things to track are the trajectory of international growth, whether pricing actions can offset input-cost inflation to stabilize gross margin, and Monster's market-share trend against the newer competitors.

Peer Cohorts (Per Segment, With Filing Citations)

Monster Energy Drinks (reported)

Strategic Brands (reported)

Alcohol Brands (reported)

Other (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Monster Q1 2026 results, 2026 · Monster FY2025 10-K

View the full interactive MNST report on boothcheck